31 August 2009
Pattern of glomerulonephritis in Iran: a preliminary study and brief review
Hassan MohammadhoseiniakbariA, Nima RezaeiE, Alireza RezaeiD, Sara Khanipour RoshanEF, Yasamin HonarbakhshCGMed Sci Monit 2009; 15(9): PH109-114 :: ID: 878161
Abstract
Background
Glomerulonephritis is a relatively rare disease with numerous subtypes and limited numbers of patients with each. Comprehensive epidemiological surveys are therefore difficult to undertake and there are few data on the spectrum of renal disease, especially in Iran. The aim was to determine the pattern of glomerulonephritis in Iran.
Material and Method
Following a retrospective study on 400 candidates for renal biopsy whose renal specimens were evaluated at the pathology department of Tehran's referral hospital during 2006 and 2007, 393 cases were registered. The biopsy specimens were processed for light and electron microscopy and one renal pathologist confirmed these diagnoses using standard diagnostic criteria.
Results
The mean +/-SD patient age was 31.9+/-15.9 (range: 3-78 years). Primary glomerulonephritis included 276 (70.2%) patients and 81(20.6%) had secondary glomerulonephritis. Of the 393 cases, 54.7% were male, 15.0% were children, and 3.8% were elderly. The most common glomerulonephritis was FSGS (37.1%) followed by MGN (16.5%) and lupus nephritis (13.4%). Furthermore, FSGS was the most common glomerulonephritis in the males (34.4%) and in all age groups.
Conclusions
These data make a small contribution to the epidemiology of glomerulonephritis in Iran, showing an epidemiological difference from a previous study in Iran and other Middle East countries, particularly an increasing prevalence of focal and segmental glomerulosclerosis. A multi-center study with a larger sample size should be performed to create an Iranian registry of renal biopsies.
Keywords: Kidney - pathology, Iran - epidemiology, Glomerulonephritis - physiopathology, Child, Preschool, Child, Biopsy, Adolescent, young adult
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952